Precision Medicine and Breast Cancer on "Arkansas Talks Health"

19 Oct 2026 in

More than a century ago, a breast cancer diagnosis came with grim odds. In 1920, the five-year survival rate for breast cancer was just 5%. Today, that figure has climbed to roughly 92%, thanks to advances in screening, treatment and research. In this episode of “Arkansas Talks Health,” medical experts discuss how precision medicine is transforming cancer care by moving away from a one-size-fits-all approach and toward treatment plans tailored to each individual patient.  

“Arkansas Talks Health” premieres Wednesday, Oct. 21, at 6 p.m.  

In this new era, technology and a deeper understanding of how cancer develops are driving advances in cancer care. Breast cancer provides one of the clearest examples of this evolution. Experts discussed how what was once treated primarily through extensive surgery is now approached with far greater precision.  

“One arm's treatment, one's prevention, and they lock together.”  
Dr. Dianne Wilder— Medical Oncologist, CARTI

The conversation also highlighted how advances extend beyond treatment. Modern imaging technologies, including 3D mammography, breast MRI and contrast-enhanced mammograms, are improving early detection rates and helping physicians find cancers sooner and at smaller sizes. Experts are utilizing these technologies and emphasize the importance of early screening.  

“Because this whole goal of early detection, early treatment, all these advances… none of them work if we can’t see the patient.”
Dr. Stephen Routon— Breast Imaging Specialist, CARTI

Groundbreaking technology and scientific advances have transformed cancer care across Arkansas, making treatment more accessible than ever. Yet experts say education and reducing the stigma around early screening and testing remain critical. Screening before symptoms develop can feel intimidating, but it can also be lifesaving.

“Part of our education is really talking, asking family members to talk about it because it will save your daughters.”
Miriam Karanja — Director of Programs, Arkansas Cancer Coalition

Panelists:
Dr. Sam Makhoul, FASCO — Medical Oncologist and Medical Director of Clinical Research, CARTI
Dr. Dianne Wilder — Medical Oncologist, CARTI
Dr. Stephen Routon — Breast Imaging Specialist, CARTI
Miriam Karanja — Director of Programs, Arkansas Cancer Coalition

Resources:  
Arkansas Cancer Coalition - A statewide non-profit network and comprehensive cancer control partnership based in Little Rock, Arkansas  
CARTI - An independent, not-for-profit cancer care provider, with 18 locations across Arkansas.  
BreastCare - A  program for Arkansas women funded with federal and state funds.  
Hope Cancer Resources - Licensed oncology social workers offer counseling, support groups and financial assistance to patients and families.  

Key Terms:  
Cascade Testing - a systematic process of extending genetic testing to biological relatives of a person diagnosed with a specific inherited genetic condition or mutation.  
Immune Therapy - A type of therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases.  
Screening - Looks for cancer before symptoms appear  
Diagnostic testing - investigates symptoms or abnormal findings

Tune In

Watch “Arkansas Talks Health” on Wednesday, Oct. 21, at 6 p.m., live on broadcast or on YouTube at YouTube.com/@arkansastv.